R Ways & Means Filed Jul 14
Bought $100K–$250K on Jun 25, 2026 · owner not disclosed
Amount$250Kband top
Asset typeU.S. Treasurygovernment debt
Filing gap19dwithin 45d
Nicole Malliotakis (R-NY), U.S. Representative, has disclosed 1 trade since 2026: 1 purchase and 0 sales. All 1 are a U.S. Treasury. The latest disclosed trade is a purchase of US TREASURY BILLS on Jun 25, 2026.
| Committee | Role |
|---|---|
| Joint Economic Committee | Member |
| House Committee on Ways and Means | Member |
| Oversight | Member |
| Tax | Member |
| Bill | Companies lobbying | Introduced | Status |
|---|---|---|---|
| Electronic Filing Improvement and Logistical Efficiency Act of 2025 | PAYXPaychex | Dec 4, 2025 | committee |
| No Tax on Overtime for All Workers Act | CSXCSX | Sep 18, 2025 | committee |
| MMEDS Act of 2025 | CORCencora | Apr 28, 2025 | committee |
| Medical Supply Chain Resiliency Act | UPSUnited Parcel Service PFEPfizer CORCencora GILDGilead Sciences | Mar 18, 2025 | committee |
| Supply Chain Security and Growth Act of 2025 | ABBVAbbVie AMGNAmgen | Feb 13, 2025 | committee |
| Supply Chain Security and Growth Act of 2024 | ABBVAbbVie | May 22, 2024 | committee |
| To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program. | AMGNAmgen CICigna Group | Jul 25, 2023 | committee |
Portrait: Image courtesy of the Member, via Congress.gov.